Asset Sales Archives - Page 70 of 70

1 minute read

Theravance Biopharma To Sell TRELEGY ELLIPTA Royalty Interests To Royalty Pharma for ~$1.1B In Upfront Cash With Over $1.5B In Potential Total Value

July 13, 4:21 PM

Over $1.5 Billion in Potential Total Value, Including Approximately $1.1 Billion in Upfront Cash, up to $250 Million in Sales-Based Milestone Payments and an Estimated NPV

RPRX

1 minute read

Australia and New Zealand Banking Group in Talks to Buy MYOB Group from KKK for $3B

By Charles Gross

July 13, 4:47 AM

-Reuters https://www.reuters.com/markets/deals/anz-confirms-discussions-with-kkr-myob-buyout-2022-07-13/

KKR

2 minute read

Cresco Labs Acquisition Of Columbia Care Creates Huge Cannabis Conglomerate And Enormous Pay-Out For This CEO

By Maureen Meehan

July 10, 12:02 PM

On Friday, Columbia Care Inc.

CCHWF

1 minute read

Citi in Talks with Russian Buyers Including Expobank and Reso-Garantia over Sale of Local Operations

By Charles Gross

July 1, 5:45 AM

-Financial Times https://www.ft.com/content/d8853759-418b-41d1-99d5-5165a0342244

2 minute read

3M to Sell Rights to Neoplast and Neobun Brands and Related Assets in Thailand and Certain other Southeast Asia Countries; Terms Not Disclosed

By Charles Gross

July 1, 4:59 AM

3M (NYSE: MMM) has entered into an agreement to sell its rights to the Neoplast™ and Neobun™ brands and related assets in Thailand and certain other Southeast Asia countries, including the manufacturing assets of its Ladlumkaew, Thailand, facility to Selic Corp Public Company Limited (Selic), a company focusing on bon

MMM